Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.
DONATE
Join The Academy as Dr. Jaime Rubin, Vice Chair for Investigator Development at Columbia University, addresses relevant topics and skills required for successful funding and grantsmanship.
This symposium presents a remarkable opportunity to convene with other researchers, clinicians, and industry leaders to discuss the extraordinary progress and immense potential of new drug therapies and technologies in paving the way for a brighter future in cancer treatment.
Scientists working in basic, translational, and clinical cancer metabolism research are invited to join the Academy in New York on April 17th to discuss the intersection between cell signaling and metabolism.
Join The Academy as Dr. Jaime Rubin, Vice Chair for Investigator Development at Columbia University, addresses relevant topics and skills required for successful funding and grantsmanship.
The Leon Levy Scholarships in Neuroscience (LLSN) aim to promote groundbreaking neuroscience research in the five boroughs of New York City. The scholarships support the most innovative young researchers at a critical stage of their careers—their postdoctoral research—as they develop the new ideas and directions that will help establish them as independent neuroscientists.
As the New York Academy of Sciences continues into its third century, Nicholas Dirks is at the helm of an extraordinary organization with a talented staff, a global community of more than 20,000 Members, and a network of top-echelon leaders in science, industry, academia, government and public policy. Bringing all these people together, the Academy is taking on COVID-19 and other world-wide challenges with the best solutions that science, technology, and bright minds can offer.
Tuesday, June 5, 2018, 12:30 PM - 5:30 PM EDT
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
Presented By
The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine to recognize biomedical scientists whose discoveries transformed the way medicine is practiced. The awardees are midcareer researchers who have made a significant impact in the understanding of human disease pathogenesis and/or treatment. Moreover, it is anticipated that they will continue to make profound advances in the general field of molecular medicine.
The 2018 Ross Prize in Molecular Medicine will be awarded to Dr. Huda Y. Zoghbi for her research unveiling the genetic and molecular basis of Rett syndrome and spinocerebellar ataxia, enabling novel therapeutic strategies for these devastating diseases. Her discovery of the mutational driver of Rett syndrome also lead to the elucidation of its role in other neurological impairments, ranging from learning disabilities to autism. Complemented by fundamental studies in neurodevelopment, Dr. Zoghbi continues to pursue the complex molecular processes driving the pathogenesis of some of the most devastating neurological conditions.
 |  |
Dominick P. Purpura Department of Neuroscience at the
Albert Einstein College of Medicine
The Kavli Institute for Brain Science
June 05, 2018
Speakers
Speaker
Speaker
Speaker
Speaker
Speaker
Speaker